CN1122709A - Medicinal powder "Shulingsan" and its prepn. containing sweet potato - Google Patents

Medicinal powder "Shulingsan" and its prepn. containing sweet potato Download PDF

Info

Publication number
CN1122709A
CN1122709A CN 94117796 CN94117796A CN1122709A CN 1122709 A CN1122709 A CN 1122709A CN 94117796 CN94117796 CN 94117796 CN 94117796 A CN94117796 A CN 94117796A CN 1122709 A CN1122709 A CN 1122709A
Authority
CN
China
Prior art keywords
shulingsan
radix
active ingredient
rhizoma dioscoreae
mixed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN 94117796
Other languages
Chinese (zh)
Inventor
柴西进
郑淑苹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN 94117796 priority Critical patent/CN1122709A/en
Publication of CN1122709A publication Critical patent/CN1122709A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The medicinal powder uses sweet potato as main raw material in addition to root of angelica dahurica, root of garden burnet and other four ingredients of traditional Chinese medicines and is prepared by the steps of high temperature drying, smashing, sifting and mixing. It is for external use only and indicated for treatment of bed sore, scald and zoster.

Description

A kind of Shulingsan and manufacture method thereof
The present invention relates to a kind ofly, especially decubital ulcer, scald and herpes zoster disease are had the Shulingsan and the manufacture method thereof of significant curative effect dermatosis, wound.
General treatment method to decubital ulcer, scald, herpes zoster is at present:
1, decubital ulcer: be subjected to compressing and cause the local circulation obstacle because of the easy apophysis of pressurized goes out the position, thus formative tissue ulceration, necrosis.Present Therapeutic Method: the 1. oil ointment or the other drug of external application antibacterial action, 2. infrared ray radiation, 3. 4. operation method of hyperbaric oxygen therapy:
2, scald: (the moistening pinkiness of wound surface or to reach subcutaneous by corium be crateriform tissue defect is with transudate and infection for any position of health, blister ulceration because of patient part is accidentally scalded by boiled water.
Present Therapeutic Method: 1. 2. 3. operative treatment of antibiotic therapy of external application Scald Ointment or Chinese medicine:
3, herpes zoster: because of body immunity low, viral infection and the dermatosis that takes place.
Present Therapeutic Method: 1. external application or subcutaneous (muscle) are injected transfer factor 2. external application or intramuscular injection Recombinant Interferon.
The present invention provides a kind ofly new has special significant curative effect to decubital ulcer, scald, herpes zoster, and the time is short, instant effect, easy to use, medicine that has no side effect and manufacture method thereof.
For reaching the purpose of foregoing invention, the present invention adopts following embodiment: the active ingredient of Shulingsan of the present invention is: a kind of Shulingsan is characterized in that its active ingredient of described Shulingsan is: Rhizoma Dioscoreae esculentae 1000g, Radix Angelicae Dahuricae 50g, Radix Sangusorbae 50g, Gypsum Fibrosum 50g, Radix Et Rhizoma Rhei 50g, Cortex Phellodendri 50g, Radix Salviae Miltiorrhizae 50g.
The manufacture method of Shulingsan of the present invention is: described active ingredient Rhizoma Dioscoreae esculentae is cleaned be cut into decoction pieces,, dried 48 hours in dehydrator with 80 ℃ of temperature, take out crushing screening 100 order powdereds afterwards; Above-mentioned all the other commercially available medicinal active ingredients evenly are mixed behind the crushing screening 100 order powdereds separately are mixed-powder; Above-mentioned Rhizoma Dioscoreae esculentae powder and all the other active ingredient mixed-powders are evenly stirred the back bottling.
The present invention makes therapeutic effect very obvious owing to adopt suitable active ingredient and manufacture method.Said as Compendium of Material Medica: " the potato nature and flavor are sweet, flat nontoxic ".Main Ingredients and Appearance in the Shulingsan is a Rhizoma Dioscoreae esculentae, and it is again the mixture of multiple material, again based on it, assistant is made herb medicinal paste for external application with Six-element medicine part compatibilities such as the Radix Angelicae Dahuricae, Radix Sangusorbaes, make Shulingsan of the present invention can be widely used in decubital ulcer, scald and herpes zoster dermatosis that the treatment a variety of causes causes, but have no side effect, apposition is convenient, and the advantage of wide, the easy processing in medicine source is more arranged.
Describe the present invention below in conjunction with embodiment: " a kind of Shulingsan is characterized in that its active ingredient of described Shulingsan is: Rhizoma Dioscoreae esculentae 1000g, Radix Angelicae Dahuricae 50g, Radix Sangusorbae 50g, Gypsum Fibrosum 50g, Radix Et Rhizoma Rhei 50g, Cortex Phellodendri 50g, Radix Salviae Miltiorrhizae 50g.”
The present invention adopts following manufacture method: described active ingredient Rhizoma Dioscoreae esculentae is cleaned be cut into decoction pieces, with 80 ℃ of temperature in dehydrator, dried 48 hours, and took out crushing screening 100 order powdereds afterwards: above-mentioned all the other commercially available medicinal active ingredients evenly are mixed behind the crushing screening 100 order powdereds separately is mixed-powder: above-mentioned Rhizoma Dioscoreae esculentae powder and all the other active ingredient mixed-powders are evenly stirred the back bottling.
Use Shulingsan 36 routine clinical effectiveness of the present invention as follows:
Using method: external application 10-50mg, every day 2-4 times
Indication: 1. skin or blister ulceration, wound surface is moistening, pinkiness;
2. reach subcutaneously by corium, be shower nozzle mouth shape, tissue defect, with
Significantly ooze out.
The case classification The example number Curative effect Percentage ratio
Cure Produce effects Effectively Invalid
Decubital ulcer is scalded herpes zoster ?15 ?16 ?5 ?15 ?16 ?5 ≈42% ≈44% ≈14%
Described as seen from the above table embodiment adopts Shulingsan therapeutic effect of the present invention all to reach the healing purpose.
Exemplify six cases below:
Case 1: admission number 135356 (302 hospitals of PLA, down together)
Lee XX, man 37 years old, seriously ill long-term bed, coccyx terminal skin ulceration in the end has courageous and upright secretions, ulceration area 3 * 3cm, degree of depth 2cm is diagnosed as the decubital ulcer III phase, uses " Shulingsan " external application 2-4 times/days, 20mg/ time, two days wound surface dryings, 5 days wounds are more, and are good so far.
Case 2: admission number 135323.
Open XX, man 44 years old, seriously ill long-term bed, the courageous and upright water bag of right hipbone portion's skin ulceration, ulceration area 2 * 2cm is diagnosed as the decubital ulcer III phase, external application " Shulingsan " 1-3 times/day, 10mg/ time the same day wound surface drying, 3 days wound healings, good so far.
Case 3, admission number 134643.
Open XX, woman's soft-fat type on the 71st, sick skin ulcer long-term bed, cervical region right side ulceration area 2 * 2cm, degree of depth 1cm, ulceration has purulent secretion, is diagnosed as bubble and examines external application " Shulingsan " 1-3 times/day, 10mg/ time, two days wound surface dryings, 4 days wound healings.
Case 4, admission number 135719
What XX, man 65 years old, seriously ill, long-term bed, formed ring waist (except that the lower back small size of right side) herpes zoster, back maximum area 7 * 5cm, degree of depth 0.5cm, a large amount of courageous and upright purulent secretions ooze out, be diagnosed as herpes zoster, external application " Shulingsan " 2-4 times/day, 10-50mg/ time, wound was all dry in 3 days, and wound healing was good so far in 10 days.
Case 5, admission number 136463
Three XX, man 22 years old, the patient is because careless, and boiled water is scalded right thigh front side skin, scalding area 4 * 4cm, the skin ulceration has courageous and upright secretions, external application " Shulingsan ", 1-3 times/days, 20mg/ time, 1 day xerosis cutis, 3 days wound healings are good so far.
Case 6 is not in hospital
Peace XX, the woman, 76 years old, the patient was because careless boiled water soup is hindered right thigh front side skin, area 4 * 4cm, left foot back and toe scalding area are 14 * 10cm, and female toe place degree of depth reaches 0.5cm, and have blood to give birth to dense sexual secretion, external application " Shulingsan " 1-3 times/day, 20-50mg/ time, wound surface was long-pending dry in 2 days, and wound healing was good so far in 7 days.

Claims (2)

1, a kind of Shulingsan is characterized in that its active ingredient of described Shulingsan is: Rhizoma Dioscoreae esculentae 1000g, Radix Angelicae Dahuricae 50g, Radix Sangusorbae 50g, Gypsum Fibrosum 50g, Radix Et Rhizoma Rhei 50g, Cortex Phellodendri 50g, Radix Salviae Miltiorrhizae 50g.
2, Shulingsan according to claim 1 is characterized in that the manufacture method of said Shulingsan is: described active ingredient Rhizoma Dioscoreae esculentae is cleaned be cut into decoction pieces,, dried 48 hours in dehydrator with 80 ℃ of temperature, take out crushing screening 100 order powdereds afterwards; Above-mentioned all the other commercially available medicinal active ingredients evenly are mixed behind the crushing screening 100 order powdereds separately are mixed-powder; Above-mentioned Rhizoma Dioscoreae esculentae powder and all the other active ingredient mixed-powders are evenly stirred the back bottling.
CN 94117796 1994-11-11 1994-11-11 Medicinal powder "Shulingsan" and its prepn. containing sweet potato Pending CN1122709A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN 94117796 CN1122709A (en) 1994-11-11 1994-11-11 Medicinal powder "Shulingsan" and its prepn. containing sweet potato

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN 94117796 CN1122709A (en) 1994-11-11 1994-11-11 Medicinal powder "Shulingsan" and its prepn. containing sweet potato

Publications (1)

Publication Number Publication Date
CN1122709A true CN1122709A (en) 1996-05-22

Family

ID=5038557

Family Applications (1)

Application Number Title Priority Date Filing Date
CN 94117796 Pending CN1122709A (en) 1994-11-11 1994-11-11 Medicinal powder "Shulingsan" and its prepn. containing sweet potato

Country Status (1)

Country Link
CN (1) CN1122709A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074282C (en) * 1996-11-18 2001-11-07 黄士相 Burn and scald ointment
CN1080574C (en) * 1999-09-03 2002-03-13 王新林 Yuchuang oinment for treating sore
CN102526307A (en) * 2012-02-16 2012-07-04 王建中 Chinese medicinal composition for treating herpes zoster
WO2020139689A1 (en) 2018-12-26 2020-07-02 Kim Katherine Echo Compositions and methods for treating burns, wounds, and skin disorders

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1074282C (en) * 1996-11-18 2001-11-07 黄士相 Burn and scald ointment
CN1080574C (en) * 1999-09-03 2002-03-13 王新林 Yuchuang oinment for treating sore
CN102526307A (en) * 2012-02-16 2012-07-04 王建中 Chinese medicinal composition for treating herpes zoster
WO2020139689A1 (en) 2018-12-26 2020-07-02 Kim Katherine Echo Compositions and methods for treating burns, wounds, and skin disorders

Similar Documents

Publication Publication Date Title
CN101648014A (en) Medicinal composition for treating skin injury and ulcer and application thereof
CN1122709A (en) Medicinal powder "Shulingsan" and its prepn. containing sweet potato
CN1958051A (en) Chinese herbal medicine for treating necrosis of femoral head, and preparation method
CN104800732A (en) Foot bath care solution for treating diabetic feet as well as preparation method and application thereof
CN1261140C (en) Medicine for treating burns and scalds
CN102872187A (en) External carbuncle cream and preparation method thereof
CN1224416C (en) Chinese medicine for treating keloid
CN101185619A (en) Hemorrhoid-eliminating shower cream and preparation method
CN104958613B (en) Chinese medicine composition of malicious decomposed type decubital ulcer and preparation method thereof is accumulate in a kind for the treatment of
CN108066572A (en) A kind of plaster for treating gonarthromeningitis and preparation method thereof
CN1056992C (en) Medicated wine for curing rheumarthritis and rheumatoid arthritis and its preparation process
CN109529022A (en) A kind of diabetic foot wound externally applied drug and its application method
CN1089002C (en) Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease
US20240091190A1 (en) Skin cream for reducing bed sores
CN1055002C (en) External-use cream for treatment of breast cancer
CN1304042C (en) Production of externally-applied for treating acne
CN105832965A (en) Traditional Chinese medicinal preparation for treating burns and scalds and preparation method of traditional Chinese medicinal preparation
CN1197604C (en) Ointment for treating burns, scalds, sore, scabies, bone tuberculosis and black red wound
CN1197605C (en) Ointment for treating burns and scalds
CN111991468A (en) Chinese herbal medicine preparation for repairing and nursing foot skin
CN114306512A (en) Ointment for promoting wound healing and preparation method thereof
CN116650585A (en) Traditional Chinese medicine for promoting wound healing after perianal abscess and anal fistula operation and preparation method thereof
CN1174740A (en) Traditional Chinese medicine for curing injuries
CN1483425A (en) Traditional Chinese medicine for treating cancer
CN114288345A (en) Medicine for treating burn and scald and its preparing method

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination